Instrument Inactif

Communiqués MyoKardia, Inc.

Actions

MYOK

US62857M1053

Recherche biotechnologique et médicale

Communiqués

17/11/20	MYOKARDIA, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
16/11/20	MyoKardia : Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten	AQ
16/11/20	MyoKardia : Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020	AQ
15/11/20	MyoKardia : Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten	AQ
15/11/20	MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten	GL
13/11/20	MyoKardia : Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020	AQ
13/11/20	MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020	GL
11/11/20	MyoKardia : Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy	AQ
11/11/20	MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy	GL
06/11/20	MyoKardia: 3Q Earnings Snapshot	AQ
05/11/20	MYOKARDIA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
05/11/20	MyoKardia : Reports Third Quarter 2020 Financial Results	AQ
05/11/20	MyoKardia Reports Third Quarter 2020 Financial Results	GL
04/11/20	MyoKardia : Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program	AQ
04/11/20	MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program	GL
03/11/20	MyoKardia : Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association's Annual Scientific Sessions 2020	AQ
02/11/20	MyoKardia : Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association’s Annual Scientific Sessions 2020	AQ
02/11/20	MyoKardia Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association’s Annual Scientific Sessions 2020	GL
09/10/20	MYOKARDIA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MyoKardia, Inc. - MYOK	BU
05/10/20	MYOKARDIA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
10/09/20	MyoKardia : Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy	AQ
09/09/20	MyoKardia : MYOK Corporate Presentation - September 2020	PU
09/09/20	MyoKardia : Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy	AQ
09/09/20	MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy	GL
02/09/20	MyoKardia to Participate in September Investor Conferences	GL